FDA Approves New RSV Monoclonal Antibody to Protect Infants

General Medicine

The US Food and Drug Administration (FDA) recently approved clesrovimab, marketed as Enflonsia, to prevent respiratory syncytial virus (RSV) lower respiratory tract infection in newborns and infants entering their first outbreak season.

Read Full Article

Journal Source :

JAMA - Journal of the American Medical Association

Sustain the Knowledge Stream!

For unrestricted access to content and a seamless experience,

Continue to Login

Don't have an account?

We’d love to get to know you better!

Complete your profile to help us deliver a more personalized experience.

Menu

FDA Approves New RSV Monoclonal Antibody to Protect Infants

Journal Source :

Comments

Questions (1/5)

Q.1:

In your opinion, what might be the diagnosis for the 11-year-old girl described in the case?

Thank You!

You score is 60%.

Total Questions

Total Right Answer

Total Wrong Answer

Sustain the Knowledge Stream!

Continue to Login

Don't have an account?

We’d love to get to know you better!